News

Stay up to date with PredictImmune

Latest News

PredictImmune and CEO Paul Kinnon announced as finalists in the Cambridge Independent Science and Technology Awards 2019

Sep 16, 2019

PredictImmune and CEO Paul Kinnon announced as finalists in the Cambridge Independent Science and Technology Awards 2019Cambridge, UK, September...

PredictImmune appoints Tim Rea of BGF as non-executive director

Aug 20, 2019

PredictImmune appoints Tim Rea of BGF as non-executive directorExperienced entrepreneur and investor appointed with immediate effect Cambridge, UK,...

PredictImmune announces closure of £10 Million series B funding round

Jul 30, 2019

PredictImmune closes Series B funding round, raising £10M to further accelerate global commercial expansion and support expanding product...

Gut publication extends follow-up for PredictImmune’s blood-based prognostic biomarker in IBD.

May 3, 2019

Gut publication extends follow-up for PredictImmune’s blood-based prognostic biomarker in IBD.Cambridge, UK, 2nd May 2019: Longer-term follow-up...

PredictImmune’s first prognostic test for IBD, PredictSURE IBD™, launches in the UK and Ireland

Apr 2, 2019

PredictImmune’s first prognostic test for IBD, PredictSURE IBD™, launches in the UK and IrelandpeThe world’s first validated prognostic test for...

PredictImmune’s first prognostic test, PredictSURE IBD™, set for UK and European launch having been awarded CE mark

Dec 11, 2018

PredictImmune’s first prognostic test, PredictSURE IBD™, set for UK and European launch having been awarded CE markAchievement marks significant...

Crohn’s Disease PROFILE Trial Protocol Published

Dec 6, 2018

Crohn’s Disease PROFILE Trial Protocol Published Cambridge, UK, 06 December 2018: The PROFILE trial is the first biomarker-stratified study in...

PredictImmune joins the British In Vitro Device Association (BIVDA)

Nov 12, 2018

PredictImmune joins the British In vitro Device Association (BIVDA)Cambridge, UK, 13th November 2018: With the launch of its first product imminent,...